Cargando…

Association of Exercise-Based Cardiac Rehabilitation with Progression of Paroxysmal to Sustained Atrial Fibrillation

Progression of atrial fibrillation (AF) is associated with worsened prognosis for cardiovascular events and mortality. Exercise-based-cardiac rehabilitation programmes have shown preliminary promise for primary and secondary prevention of AF. Yet, such interventions are typically reserved for patien...

Descripción completa

Detalles Bibliográficos
Autores principales:	Buckley, Benjamin J. R., Harrison, Stephanie L., Fazio-Eynullayeva, Elnara, Underhill, Paula, Lane, Deirdre A., Thijssen, Dick H. J., Lip, Gregory Y. H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Brief Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7865453/ https://www.ncbi.nlm.nih.gov/pubmed/33498648 http://dx.doi.org/10.3390/jcm10030435

Ejemplares similares

Exercise‐Based Cardiac Rehabilitation and All‐Cause Mortality Among Patients With Atrial Fibrillation
por: Buckley, Benjamin J. R., et al.
Publicado: (2021)

Atrial fibrillation and the risk of 30‐day incident thromboembolic events, and mortality in adults ≥ 50 years with COVID‐19
por: Harrison, Stephanie L., et al.
Publicado: (2020)

Atrial Fibrillation in Patients With Cardiomyopathy: Prevalence and Clinical Outcomes From Real‐World Data
por: Buckley, Benjamin J. R., et al.
Publicado: (2021)

Comorbidities associated with mortality in 31,461 adults with COVID-19 in the United States: A federated electronic medical record analysis
por: Harrison, Stephanie L., et al.
Publicado: (2020)

End-Stage renal disease and 30-day mortality for adults with and without COVID-19
por: Harrison, Stephanie L., et al.
Publicado: (2021)

Atrial Fibrillation Specific Exercise Rehabilitation: Are We There Yet?
por: Buckley, Benjamin J. R., et al.
Publicado: (2022)

Outcomes of left atrial appendage occlusion vs. non-vitamin K antagonist oral anticoagulants in atrial fibrillation
por: Ding, Wern Yew, et al.
Publicado: (2022)

Validation of the modified Microlife blood pressure monitor in patients with paroxysmal atrial fibrillation
por: Huppertz, Nina, et al.
Publicado: (2019)

Efficacy and safety of direct-acting oral anticoagulants compared to vitamin K antagonists in COVID-19 outpatients with cardiometabolic diseases
por: Rivera-Caravaca, José Miguel, et al.
Publicado: (2021)

Direct-acting oral anticoagulants use prior to COVID-19 diagnosis and associations with 30-day clinical outcomes
por: Rivera-Caravaca, José Miguel, et al.
Publicado: (2021)

Risk of myocardial infarction and ischemic stroke in individuals with first-diagnosed paroxysmal vs. non-paroxysmal atrial fibrillation under anticoagulation
por: Ntaios, George, et al.
Publicado: (2023)

The Atrial Fibrillation Better Care pathway for managing atrial fibrillation: a review
por: Stevens, David, et al.
Publicado: (2021)

Irisin is an Effector Molecule in Exercise Rehabilitation Following Myocardial Infarction (Review)
por: Qin, Shuguang, et al.
Publicado: (2022)

Stroke and Bleeding Risk in Atrial Fibrillation
por: Senoo, Keitaro, et al.
Publicado: (2014)

Stroke and bleeding risk stratification in atrial fibrillation: a critical appraisal
por: Lane, Deirdre A, et al.
Publicado: (2020)

Stroke and Bleeding Risk Assessments in Patients With Atrial Fibrillation: Concepts and Controversies
por: Ding, Wern Yew, et al.
Publicado: (2020)

Prevalence and determinants of atrial fibrillation progression in paroxysmal atrial fibrillation
por: Nguyen, Bao-Oanh, et al.
Publicado: (2023)

Clinical implications of different types of dementia in patients with atrial fibrillation: Insights from a global federated health network analysis
por: Proietti, Riccardo, et al.
Publicado: (2023)

Suppression of Paroxysmal Atrial Fibrillation by Pacing
por: Gupta, Anoop K
Publicado: (2003)

Paroxysmal atrial fibrillation in cryptogenic stroke
por: Dangayach, Neha S, et al.
Publicado: (2011)

Hypoadiponectinemia in Patients With Paroxysmal Atrial Fibrillation
por: Choi, Byung Joo, et al.
Publicado: (2012)

Thromboembolic risks associated with paroxysmal and persistent atrial fibrillation in Asian patients: a report from the Chinese atrial fibrillation registry
por: Wang, Ying, et al.
Publicado: (2019)

Anticoagulation Control in Older Atrial Fibrillation Patients Receiving Vitamin K Antagonist Therapy for Stroke Prevention
por: Zulkifly, Hanis, et al.
Publicado: (2022)

Patients' Perceptions of Atrial Fibrillation, Stroke Risk, and Oral Anticoagulation Treatment: An International Survey
por: Lane, Deirdre A., et al.
Publicado: (2018)

Evolving Effect of the COVID-19 Pandemic on Cancer-Related Encounters
por: London, Jack W., et al.
Publicado: (2022)

207. Burden of Post-Transplant Neutropenia and Leukopenia among Kidney Transplant Recipients: A Multi-Institutional Real-World Observational Study
por: Raval, Amit D, et al.
Publicado: (2022)

Comprehensive Management With the ABC (Atrial Fibrillation Better Care) Pathway in Clinically Complex Patients With Atrial Fibrillation: A Post Hoc Ancillary Analysis From the AFFIRM Trial
por: Proietti, Marco, et al.
Publicado: (2020)

Associations between COVID-19 and 30-day thromboembolic events and mortality in people with dementia receiving antipsychotic medications
por: Harrison, Stephanie L., et al.
Publicado: (2021)

Temporal Trends in Incidence, Prevalence, and Mortality of Atrial Fibrillation in Primary Care
por: Lane, Deirdre A., et al.
Publicado: (2017)

Atrial fibrillation patient preferences for oral anticoagulation and stroke knowledge: Results of a conjoint analysis
por: Lane, Deirdre A., et al.
Publicado: (2018)

Contemporary management of atrial fibrillation in primary and secondary care in the UK: the prospective long-term AF-GEN-UK Registry
por: Shantsila, Alena, et al.
Publicado: (2022)

Left atrial effective conducting size predicts atrial fibrillation vulnerability in persistent but not paroxysmal atrial fibrillation
por: Williams, Steven E., et al.
Publicado: (2019)

Pregnancy-Related Complications and Incidence of Atrial Fibrillation: A Systematic Review
por: Al Bahhawi, Tariq, et al.
Publicado: (2023)

Diagnosing Paroxysmal Atrial Fibrillation: Are Biomarkers the Solution to This Elusive Arrhythmia?
por: Howlett, P. J., et al.
Publicado: (2015)

Detection of Paroxysmal Atrial Fibrillation in Stroke/Tia Patients
por: Khan, Muhib, et al.
Publicado: (2013)

Educational Intervention Improves Anticoagulation Control in Atrial Fibrillation Patients: The TREAT Randomised Trial
por: Clarkesmith, Danielle E., et al.
Publicado: (2013)

Natriuretic peptides for the detection of paroxysmal atrial fibrillation
por: Seegers, Joachim, et al.
Publicado: (2015)

Balloon Cryoablation for the Treatment of Paroxysmal Atrial Fibrillation
por: Fenelon, Guilherme, et al.
Publicado: (2017)

Cryoballoon Ablation for Patients With Paroxysmal Atrial Fibrillation
por: Suenari, Kazuyoshi, et al.
Publicado: (2020)

Cardiac rehabilitation meta-analysis of trials in patients with coronary heart disease using individual participant data (CaReMATCH): Project protocol
por: Buckley, Benjamin J.R., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_o303n32cq6a1a4j9m4clavrj9c